0000929638-24-004038.txt : 20241125 0000929638-24-004038.hdr.sgml : 20241125 20241125110318 ACCESSION NUMBER: 0000929638-24-004038 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241118 FILED AS OF DATE: 20241125 DATE AS OF CHANGE: 20241125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Biosion, Inc. CENTRAL INDEX KEY: 0002045933 ORGANIZATION NAME: STATE OF INCORPORATION: F4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37581 FILM NUMBER: 241492934 BUSINESS ADDRESS: STREET 1: 5TH FLOOR, BUILDING D STREET 2: 3-1 ZHONGDAN UNIT, SOUTH LONGSHAN RD CITY: NANJING STATE: F4 ZIP: 210061 BUSINESS PHONE: 267-356-9574 MAIL ADDRESS: STREET 1: 5TH FLOOR, BUILDING D STREET 2: 3-1 ZHONGDAN UNIT, SOUTH LONGSHAN RD CITY: NANJING STATE: F4 ZIP: 210061 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aclaris Therapeutics, Inc. CENTRAL INDEX KEY: 0001557746 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 460571712 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 701 LEE ROAD STREET 2: SUITE 103 CITY: WAYNE STATE: PA ZIP: 19087 BUSINESS PHONE: 484-324-7933 MAIL ADDRESS: STREET 1: 701 LEE ROAD STREET 2: SUITE 103 CITY: WAYNE STATE: PA ZIP: 19087 3 1 form3.xml X0206 3 2024-11-18 0 0001557746 Aclaris Therapeutics, Inc. ACRS 0002045933 Biosion, Inc. 5TH FLOOR, BUILDING D 3-1 ZHONGDAN UNIT, SOUTH LONGSHAN RD NANJING F4 210061 CHINA true Warrants (right to buy) 0.0001 2024-11-18 Common Stock 11281985 D On November 18, 2024, Aclaris Therapeutics, Inc. ("Aclaris") and Biosion, Inc. ("Biosion") entered into a Common Stock Purchase Warrant (the "Warrant"). Pursuant to the Warrant, Biosion, its designee or its permitted assigns, upon meeting certain terms and conditions of the Warrant, is entitled to exercise the warrant for up to 11,281,985 shares of Aclaris Common Stock. The Warrant was exercisable as of November, 18 2024 and may be exercised until the date on which the Warrant is exercised in full. /s/ Biosion, Inc. by: MINGJIU CHEN, CEO 2024-11-25